Literature DB >> 17645379

Merkel cell carcinoma in a liver transplant patient.

Houdna Bensaleh1, Pascal Perney, Olivier Dereure, Jean-Jacques Guilhou, Bernard Guillot.   

Abstract

Merkel cell carcinoma (MCC) is an aggressive tumor, the incidence of which is seemingly increased in immunocompromised patients. We report on a new case of MCC occurring in a 69-year-old male liver transplant recipient 6.5 years after transplantation. The outcome was marked by early skin and lymph node relapses treated by radiotherapy alone, and the patient ultimately died 30 months after first diagnosis. Together with data from the literature, this case emphasizes the importance of early diagnosis and adequate management of this aggressive disease for which wide initial surgical excision, accurate staging, and close follow-up are of critical importance to outcome, especially in this setting of immunosuppressive treatment, which is usually associated with a higher rate of recurrence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645379     DOI: 10.2165/00128071-200708040-00006

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  4 in total

Review 1.  Merkel cell carcinoma.

Authors:  Emma Ramahi; Jehee Choi; Clifton D Fuller; Tony Y Eng
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

Review 2.  Merkel cell carcinoma of the forehead area: a literature review and case report.

Authors:  Claudio Caldarelli; Umberto Autorino; Caterina Iaquinta; Andrea De Marchi
Journal:  Oral Maxillofac Surg       Date:  2019-07-24

3.  Merkel cell carcinoma of skin-current controversies and recommendations.

Authors:  Avi Assouline; Patricia Tai; Kurian Joseph; Ji Dong Lian; Claude Krzisch; Edward Yu
Journal:  Rare Tumors       Date:  2011-04-04

4.  Merkel cell polyomavirus and Merkel cell carcinoma, France.

Authors:  Vincent Foulongne; Nicolas Kluger; Olivier Dereure; Natalie Brieu; Bernard Guillot; Michel Segondy
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.